Isomorphic Labs is hosting the Fragments X event
Public source
Company
Isomorphic Labs
We are reimagining the entire drug discovery process from first principles with an AI-first approach.
- Industry
- Biotechnology Research
- Location
- London, GB
- Company size
- 201–500 employees
About Isomorphic Labs
Isomorphic Labs is here to advance human health by building on and beyond the Nobel-winning AlphaFold system. Our interdisciplinary team has developed a unified, state-of-the-art drug design engine that will transform how we design new drugs, and ultimately change the way medicine will help and heal people. Every day, and with each new breakthrough, we’re getting closer to achieving our ambitious mission to one day solve all disease
See moreLatest activity
Latest activity from Isomorphic Labs
3 signals
Discover more
Similar signals
Similar public activity from other companies.
Presence & Recognition
Inductive Bio
Inductive Bio is hosting the AI in Drug Discovery Xchange conference in San Francisco on September 9.
Presence & Recognition
TandemAI
TandemAI is hosting the AI Agents in Drug Discovery 2026 forum featuring keynote presentations and panel discussions on AI/ML, physics-based computation, and drug discovery.
Presence & Recognition
Variational AI
Variational AI is attending the ALL IN 2026 event in Montréal on September 16 and 17.
Presence & Recognition
ScienceMachine
ScienceMachine will attend the EBF AI in Bioanalysis Workshop next week
Presence & Recognition
Roche